|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.520 USD | -3.08% |
|
-6.32% | +54.60% |
| 07-08 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 07-08 | Ovid Therapeutics Inc. Announces CFO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 470M | - | - | - | ||
| 54.63B | |||||
| 54.88B | |||||
| 25.06B | - | ||||
| 23.14B | - | ||||
| 19.88B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
